LAMEA IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa IVD In Cardiology And Neurology Market would witness market growth of 12.1% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA IVD In Cardiology And Neurology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $562.5 million by 2030. The Argentina market is showcasing a CAGR of 12.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.7% during (2023 - 2030).

Incorporating genomics into intravenous disease (IVD) tests facilitates accurate risk stratification, empowering medical professionals to detect individuals more susceptible to the onset of cardiovascular or neurological ailments. This information empowers clinicians to tailor preventive strategies, lifestyle recommendations, and therapeutic interventions based on an individual's genetic predispositions. Personalized treatment plans enhance the efficacy of interventions, leading to more targeted and efficient patient care.

Furthermore, liquid biopsy, a non-invasive diagnostic approach, is gaining traction in neurology. This innovative technique involves analyzing circulating biomarkers, such as DNA, RNA, or proteins, in the bloodstream. In neuro-oncology, liquid biopsy is promising for early cancer detection, treatment response monitoring, and minimal residual disease detection. By identifying specific genetic mutations or alterations associated with brain tumors, liquid biopsy enables clinicians to detect the presence of cancerous cells at an early stage. Early detection is crucial for timely interventions and improved patient outcomes.

Middle East has witnessed an increase in cardiovascular disease (CVD) cases over recent years. As per the National Library of Medicine, the Middle East has a high rate of cardiovascular disease (10.1%). In this region, the prevalence of dyslipidemia (43.3%) is double that of hypertension (26.2%) and diabetes mellitus (16%). Multifaceted interventions are desperately needed in this region for CVD primary prevention. Hence, the rising number of cardiovascular disease cases and healthcare sector growth in LAMEA will assist in the growth of the regional market.

Based on Product Type, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. Based on End Use, the market is segmented into Hospitals, Clinical Laboratories, and Others. Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Hematology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Sysmex Corporation
Siemens Healthineers AG (Siemens AG)
Quest Diagnostics Incorporated
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
Becton, Dickinson and Company
Natera, Inc.

LAMEA IVD In Cardiology And Neurology Market Report Segmentation

By Product Type

Reagents & Consumables
Instruments
Software & Services

By End Use

Hospitals
Clinical Laboratories
Others

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1LAMEA IVD In Cardiology And Neurology Market, by Product Type
- 1.4.2LAMEA IVD In Cardiology And Neurology Market, by End Use
- 1.4.3LAMEA IVD In Cardiology And Neurology Market, by Technology
- 1.4.4LAMEA IVD In Cardiology And Neurology Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.LAMEA IVD In Cardiology And Neurology Market by Product Type

4.1LAMEA Reagents & Consumables Market by Country
4.2LAMEA Instruments Market by Country
4.3LAMEA Software & Services Market by Country

Chapter 5.LAMEA IVD In Cardiology And Neurology Market by End-use

5.1LAMEA Hospitals Market by Country
5.2LAMEA Clinical Laboratories Market by Country
5.3LAMEA Others Market by Country

Chapter 6.LAMEA IVD In Cardiology And Neurology Market by Technology

6.1LAMEA Immunoassays Market by Country
6.2LAMEA Molecular Diagnostics Market by Country
6.3LAMEA Hematology Market by Country
6.4LAMEA Others Market by Country

Chapter 7.LAMEA IVD In Cardiology And Neurology Market by Country

7.1Brazil IVD In Cardiology And Neurology Market
- 7.1.1Brazil IVD In Cardiology And Neurology Market by Product Type
- 7.1.2Brazil IVD In Cardiology And Neurology Market by End-use
- 7.1.3Brazil IVD In Cardiology And Neurology Market by Technology
7.2Argentina IVD In Cardiology And Neurology Market
- 7.2.1Argentina IVD In Cardiology And Neurology Market by Product Type
- 7.2.2Argentina IVD In Cardiology And Neurology Market by End-use
- 7.2.3Argentina IVD In Cardiology And Neurology Market by Technology
7.3UAE IVD In Cardiology And Neurology Market
- 7.3.1UAE IVD In Cardiology And Neurology Market by Product Type
- 7.3.2UAE IVD In Cardiology And Neurology Market by End-use
- 7.3.3UAE IVD In Cardiology And Neurology Market by Technology
7.4Saudi Arabia IVD In Cardiology And Neurology Market
- 7.4.1Saudi Arabia IVD In Cardiology And Neurology Market by Product Type
- 7.4.2Saudi Arabia IVD In Cardiology And Neurology Market by End-use
- 7.4.3Saudi Arabia IVD In Cardiology And Neurology Market by Technology
7.5South Africa IVD In Cardiology And Neurology Market
- 7.5.1South Africa IVD In Cardiology And Neurology Market by Product Type
- 7.5.2South Africa IVD In Cardiology And Neurology Market by End-use
- 7.5.3South Africa IVD In Cardiology And Neurology Market by Technology
7.6Nigeria IVD In Cardiology And Neurology Market
- 7.6.1Nigeria IVD In Cardiology And Neurology Market by Product Type
- 7.6.2Nigeria IVD In Cardiology And Neurology Market by End-use
- 7.6.3Nigeria IVD In Cardiology And Neurology Market by Technology
7.7Rest of LAMEA IVD In Cardiology And Neurology Market
- 7.7.1Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type
- 7.7.2Rest of LAMEA IVD In Cardiology And Neurology Market by End-use
- 7.7.3Rest of LAMEA IVD In Cardiology And Neurology Market by Technology

Chapter 8.Company Profiles

8.1Thermo Fisher Scientific, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expenses
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Partnerships, Collaborations, and Agreements:
- 8.1.6SWOT Analysis
8.2F. Hoffmann-La Roche Ltd.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
8.3Sysmex Corporation
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5SWOT Analysis
8.4Siemens Healthineers AG (Siemens AG)
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Partnerships, Collaborations, and Agreements:
- 8.4.6SWOT Analysis
8.5Quest Diagnostics Incorporated
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental Analysis
- 8.5.4Recent strategies and developments:
  - 8.5.4.1Acquisition and Mergers:
- 8.5.5SWOT Analysis
8.6Abbott Laboratories
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Partnerships, Collaborations, and Agreements:
  - 8.6.5.2Acquisition and Mergers:
- 8.6.6SWOT Analysis
8.7Bio-Rad laboratories, Inc.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5SWOT Analysis
8.8Danaher Corporation (Beckman Coulter)
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9Becton, Dickinson, and Company
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expense
- 8.9.5SWOT Analysis
8.10.Natera Inc.
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1LAMEA IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 2LAMEA IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 3LAMEA IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 4LAMEA IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 5LAMEA Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6LAMEA Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7LAMEA Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8LAMEA Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 10LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 11LAMEA IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 12LAMEA IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 13LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15LAMEA Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 16LAMEA Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 17LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 18LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 19LAMEA IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 20LAMEA IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 21LAMEA Immunoassays Market by Country, 2019 - 2022, USD Million
TABLE 22LAMEA Immunoassays Market by Country, 2023 - 2030, USD Million
TABLE 23LAMEA Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24LAMEA Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25LAMEA Hematology Market by Country, 2019 - 2022, USD Million
TABLE 26LAMEA Hematology Market by Country, 2023 - 2030, USD Million
TABLE 27LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 28LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 29LAMEA IVD In Cardiology And Neurology Market by Country, 2019 - 2022, USD Million
TABLE 30LAMEA IVD In Cardiology And Neurology Market by Country, 2023 - 2030, USD Million
TABLE 31Brazil IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 32Brazil IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 33Brazil IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 34Brazil IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 35Brazil IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 36Brazil IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 37Brazil IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 38Brazil IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 39Argentina IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 40Argentina IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 41Argentina IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 42Argentina IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 43Argentina IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 44Argentina IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 45Argentina IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 46Argentina IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 47UAE IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 48UAE IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 49UAE IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 50UAE IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 51UAE IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 52UAE IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 53UAE IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 54UAE IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 55Saudi Arabia IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 56Saudi Arabia IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 57Saudi Arabia IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 58Saudi Arabia IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 59Saudi Arabia IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 60Saudi Arabia IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 61Saudi Arabia IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 62Saudi Arabia IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 63South Africa IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 64South Africa IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 65South Africa IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 66South Africa IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 67South Africa IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 68South Africa IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 69South Africa IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 70South Africa IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 71Nigeria IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 72Nigeria IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 73Nigeria IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 74Nigeria IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 75Nigeria IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 76Nigeria IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 77Nigeria IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 78Nigeria IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 79Rest of LAMEA IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 80Rest of LAMEA IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 81Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 82Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 83Rest of LAMEA IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 84Rest of LAMEA IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 85Rest of LAMEA IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 86Rest of LAMEA IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 87Key Information - Thermo Fisher Scientific, Inc.
TABLE 88Key Information - F. Hoffmann-La Roche Ltd.
TABLE 89Key Information - Sysmex Corporation
TABLE 90Key Information - Siemens Healthineers AG
TABLE 91Key information - Quest Diagnostics Incorporated
TABLE 92Key Information - Abbott Laboratories
TABLE 93Key Information - Bio-Rad Laboratories, Inc.
TABLE 94Key Information - Danaher Corporation
TABLE 95Key Information - Becton, Dickinson and Company
TABLE 96Key Information - Natera Inc.

LAMEA IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents